Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study

Abstract Background Juvenile idiopathic arthritis-associated uveitis (JIAU) typically takes a chronic course, frequently leading to ocular complications and often requiring long-term treatment. The present study assesses the 5-years outcome of JIAU by analyzing data from a prospective study initiate...

Full description

Saved in:
Bibliographic Details
Main Authors: Karoline Baquet-Walscheid, Kirsten Minden, Martina Niewerth, Frank Dressler, Ivan Foeldvari, Dirk Foell, Johannes-Peter Haas, Gerd Horneff, Anton Hospach, Tilmann Kallinich, Jasmin Kümmerle-Deschner, Kirsten Mönkemöller, Christoph Tappeiner, Daniel Windschall, Jens Klotsche, Arnd Heiligenhaus
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13075-025-03531-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849390322441781248
author Karoline Baquet-Walscheid
Kirsten Minden
Martina Niewerth
Frank Dressler
Ivan Foeldvari
Dirk Foell
Johannes-Peter Haas
Gerd Horneff
Anton Hospach
Tilmann Kallinich
Jasmin Kümmerle-Deschner
Kirsten Mönkemöller
Christoph Tappeiner
Daniel Windschall
Jens Klotsche
Arnd Heiligenhaus
author_facet Karoline Baquet-Walscheid
Kirsten Minden
Martina Niewerth
Frank Dressler
Ivan Foeldvari
Dirk Foell
Johannes-Peter Haas
Gerd Horneff
Anton Hospach
Tilmann Kallinich
Jasmin Kümmerle-Deschner
Kirsten Mönkemöller
Christoph Tappeiner
Daniel Windschall
Jens Klotsche
Arnd Heiligenhaus
author_sort Karoline Baquet-Walscheid
collection DOAJ
description Abstract Background Juvenile idiopathic arthritis-associated uveitis (JIAU) typically takes a chronic course, frequently leading to ocular complications and often requiring long-term treatment. The present study assesses the 5-years outcome of JIAU by analyzing data from a prospective study initiated in 2010. Methods Data from 75 patients with onset of uveitis after study enrollment, and with a documentation at 5-years follow-up (5yFU) were available for analysis of uveitis characteristics, frequency and predictors of „inactivity on medication “ (defined as inactive uveitis for ≥ 6 months) and „inactivity off medication “ (defined as inactive uveitis for ≥ 6 months off medication). Results At the 5yFU, visual acuity remained good in the majority of eyes (LogMAR < 0.1 in 65.5%; mean LogMAR 0.11 ± 0.31), ocular surgery was required in only 5% of patients, although complications occurred in 46.7% of patients until the 5yFU. Uveitis was inactive in 85.3% of patients, with 77.3% still receiving disease-modifying antirheumatic drugs (DMARDs). Until 5yFU, 82.7% of patients experienced ≥ one episode of „inactivity on medication “ (30.7% once, 37.3% twice, 14.7% three or more times), and 17.3% ≥ one episode of „inactivity off medication “, respectively. Both „inactivity on medication “ as well as „inactivity off medication “ were associated with lower JIA disease activity (cJADAS10; ESR), and with an increased quality of life. Conclusions Despite intensified DMARD treatment, almost half of the children experience JIAU-related ocular complications after 5 years of disease; however, visual acuity mostly remains good. Uveitis inactivity can be achieved frequently, but is often limited in duration. Lower JIA activity appears to correlate with uveitis inactivity on and off medication.
format Article
id doaj-art-4b076bdf30b344f7b3fb49fc614b3271
institution Kabale University
issn 1478-6362
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series Arthritis Research & Therapy
spelling doaj-art-4b076bdf30b344f7b3fb49fc614b32712025-08-20T03:41:42ZengBMCArthritis Research & Therapy1478-63622025-03-0127111110.1186/s13075-025-03531-wCourse of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) studyKaroline Baquet-Walscheid0Kirsten Minden1Martina Niewerth2Frank Dressler3Ivan Foeldvari4Dirk Foell5Johannes-Peter Haas6Gerd Horneff7Anton Hospach8Tilmann Kallinich9Jasmin Kümmerle-Deschner10Kirsten Mönkemöller11Christoph Tappeiner12Daniel Windschall13Jens Klotsche14Arnd Heiligenhaus15Department of Ophthalmology at St. Franziskus HospitalDeutsches Rheumaforschungszentrum BerlinDeutsches Rheumaforschungszentrum BerlinDepartment of Pediatrics, Hannover Medical SchoolHamburg Centre for Paediatric and Adolescent Rheumatology, Schön Klinik Hamburg EilbekDepartment of Pediatric Rheumatology and Immunology, University Hospital MuensterGerman Center for Pediatric and Adolescent RheumatologyCentre for Paediatric Rheumatology, Department of Paediatrics, Asklepios Clinic Sankt AugustinCentre of Paediatric Rheumatology, Olga HospitalDepartment of Paediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu BerlinAutoinflammation Reference Center Tübingen (Arct), Division of Paediatric Rheumatology, Department of Paediatrics, University Hospital TübingenDepartment of Pediatric and Adolescent Medicine, Kliniken Der Stadt Köln gGmbHUniversity of Duisburg-EssenPediatric Rheumatology, St. Josef-StiftDeutsches Rheumaforschungszentrum BerlinDepartment of Ophthalmology at St. Franziskus HospitalAbstract Background Juvenile idiopathic arthritis-associated uveitis (JIAU) typically takes a chronic course, frequently leading to ocular complications and often requiring long-term treatment. The present study assesses the 5-years outcome of JIAU by analyzing data from a prospective study initiated in 2010. Methods Data from 75 patients with onset of uveitis after study enrollment, and with a documentation at 5-years follow-up (5yFU) were available for analysis of uveitis characteristics, frequency and predictors of „inactivity on medication “ (defined as inactive uveitis for ≥ 6 months) and „inactivity off medication “ (defined as inactive uveitis for ≥ 6 months off medication). Results At the 5yFU, visual acuity remained good in the majority of eyes (LogMAR < 0.1 in 65.5%; mean LogMAR 0.11 ± 0.31), ocular surgery was required in only 5% of patients, although complications occurred in 46.7% of patients until the 5yFU. Uveitis was inactive in 85.3% of patients, with 77.3% still receiving disease-modifying antirheumatic drugs (DMARDs). Until 5yFU, 82.7% of patients experienced ≥ one episode of „inactivity on medication “ (30.7% once, 37.3% twice, 14.7% three or more times), and 17.3% ≥ one episode of „inactivity off medication “, respectively. Both „inactivity on medication “ as well as „inactivity off medication “ were associated with lower JIA disease activity (cJADAS10; ESR), and with an increased quality of life. Conclusions Despite intensified DMARD treatment, almost half of the children experience JIAU-related ocular complications after 5 years of disease; however, visual acuity mostly remains good. Uveitis inactivity can be achieved frequently, but is often limited in duration. Lower JIA activity appears to correlate with uveitis inactivity on and off medication.https://doi.org/10.1186/s13075-025-03531-wUveitisJuvenile idiopathic arthritisPrognosisBiological therapy
spellingShingle Karoline Baquet-Walscheid
Kirsten Minden
Martina Niewerth
Frank Dressler
Ivan Foeldvari
Dirk Foell
Johannes-Peter Haas
Gerd Horneff
Anton Hospach
Tilmann Kallinich
Jasmin Kümmerle-Deschner
Kirsten Mönkemöller
Christoph Tappeiner
Daniel Windschall
Jens Klotsche
Arnd Heiligenhaus
Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study
Arthritis Research & Therapy
Uveitis
Juvenile idiopathic arthritis
Prognosis
Biological therapy
title Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study
title_full Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study
title_fullStr Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study
title_full_unstemmed Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study
title_short Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study
title_sort course of uveitis in children with juvenile idiopathic arthritis jia five years follow up data from a prospective multicenter inception cohort of newly diagnosed patients with jia icon jia study
topic Uveitis
Juvenile idiopathic arthritis
Prognosis
Biological therapy
url https://doi.org/10.1186/s13075-025-03531-w
work_keys_str_mv AT karolinebaquetwalscheid courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT kirstenminden courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT martinaniewerth courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT frankdressler courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT ivanfoeldvari courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT dirkfoell courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT johannespeterhaas courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT gerdhorneff courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT antonhospach courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT tilmannkallinich courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT jasminkummerledeschner courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT kirstenmonkemoller courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT christophtappeiner courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT danielwindschall courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT jensklotsche courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy
AT arndheiligenhaus courseofuveitisinchildrenwithjuvenileidiopathicarthritisjiafiveyearsfollowupdatafromaprospectivemulticenterinceptioncohortofnewlydiagnosedpatientswithjiaiconjiastudy